SNPX Synaptogenix Inc
1,802
$4.52
$0.05
(1.09%)
| Watchers | 1,802 |
| 52-Wk Low | $3.53 |
| 52-Wk High | $47.00 |
| Market Cap | $4.91M |
| Volume | 38,642.00 |
| 52-Wk High | $47.00 |
| 52-Wk Low | $3.53 |
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug DiscoveryPR Newswire • 7 days ago
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and...
Share to Feed
Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing PR Newswire NEW YORK, April 3, 2024 Common stock will begin...
Synaptogenix, Inc. (NASDAQ:SNPX - Get Free Report) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 426,600 shares, a decline...